학술논문

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma
Document Type
Article
Source
In Blood 7 September 2023 142(10):878-886
Subject
Clinical Trials and Observations
Free Research Articles
Lymphoid Neoplasia
Language
ISSN
0006-4971